Filana Therapeutics, Inc.
FLNA
Rank in Stocks
#25784
Filana Therapeutics, Inc. is a company dedicated to pioneering new... Filana Therapeutics, Inc. is a company dedicated to pioneering new pharmaceutical products and diagnostic technologies. A key area of its research is focused on creating potential treatments for Alzheimer's disease, including the investigational compounds PTI-125 and PTI-125Dx. Established by Remi Barbier in May 1998, the firm maintains its principal office in Austin, Texas.
Share Price
$0.4923
Last synced: 2026-11-09
Market Cap
$23.78M
Change (1 day)
8.75%
Change (1 year)
-
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Filana Therapeutics, Inc. (FLNA)
Category
Healthcare
EPS for Filana Therapeutics, Inc. (FLNA)
EPS as of September 2026 TTM: $-0.87
According to Filana Therapeutics, Inc.'s latest financial reports, its current EPS (TTM) is $-0.87. At the end of 2025 the company had an EPS of $-1.88, a decrease compared to its 2024 EPS of $-0.53.
EPS history for Filana Therapeutics, Inc. from 2006 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.87 | -53.72% |
| 2025 | $-1.88 | 254.72% |
| 2024 | $-0.53 | -77.16% |
| 2023 | $-2.32 | 22.11% |
| 2022 | $-1.90 | 131.71% |
| 2021 | $-0.82 | 241.67% |
| 2020 | $-0.24 | -11.11% |
| 2019 | $-0.27 | -55.74% |
| 2018 | $-0.61 | -66.48% |
| 2017 | $-1.82 | -21.21% |
| 2016 | $-2.31 | 6.45% |
| 2015 | $-2.17 | 14.81% |
| 2014 | $-1.89 | -138.57% |
| 2013 | $4.90 | -975.00% |
| 2012 | $-0.56 | 33.33% |
| 2011 | $-0.42 | -78.57% |
| 2010 | $-1.96 | 250.00% |
| 2009 | $-0.56 | -122.22% |
| 2008 | $2.52 | -21.74% |
| 2007 | $3.22 | 228.57% |
| 2006 | $0.98 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -1,900.00% |
US
|
|
| $-7.07 | 712.64% |
US
|
|
| $-5.29 | 508.05% |
AU
|
|
| $12.88 | -1,580.47% |
BE
|
|
| $21.56 | -2,578.16% |
NL
|
Questions about Filana Therapeutics, Inc.'s earnings per share (EPS)
What is Filana Therapeutics, Inc.'s earnings per share (EPS)?
Filana Therapeutics, Inc.'s earnings per share (EPS) over the last twelve months is $-0.87, as of Sep 2026.
What was Filana Therapeutics, Inc.'s earnings per share (EPS) in 2025?
In 2025, Filana Therapeutics, Inc.'s earnings per share (EPS) was $-1.88, compared with $-0.53 in 2024.
How has Filana Therapeutics, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Filana Therapeutics, Inc.'s earnings per share (EPS) was highest in 2020 ($-0.24) and lowest in 2023 ($-2.32).
How does Filana Therapeutics, Inc.'s earnings per share (EPS) compare with similar companies?
Filana Therapeutics, Inc.'s earnings per share (EPS) ($-0.87) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.